Boston & New England CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
The Davis Companies Acquires Biomanufacturing Facility, Development Parcel in Smithfield
Boston, MA-based The Davis Companies has acquired an improved 122,000-square-foot biomanufacturing facility at 100 Technology Way in Smithfield, RI. The acquisition also includes a vacant 15.5-acre development parcel with master plan approvals for an additional biotech manufacturing facility of up to 175,000 square feet.
Real estate investment, development and management firm The Davis Companies purchased 100 Technology Way from Rubius Therapeutics, a Flagship Pioneering portfolio company, which acquired it from Alexion Pharmaceuticals in 2018 and invested in extensive improvements to the building as well as in significant infrastructure and equipment which The Davis Companies also acquired.
“There is a growing need in the life science industry for process development and small-batch testing ahead of clinical trials,” said Cappy Daume, The Davis Companies’ chief portfolio management officer.
Mark Winters and Tyler McGrail of Newmark are handling lease-up of the property, which is situated just off Interstate 295.
- ◦Sale/Acquisition
